Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shantan Reddy, MD
Lousiana Health Sciences Center - Shreveport
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham Hematology and Oncology Associates, Llc
Birmingham, Alabama, United States
- Mayo Clinic Arizona
Scottsdale, Arizona, United States
- Arizona Oncology Associates, Pc - Hope
Tucson, Arizona, United States
- University of Arizona
Tucson, Arizona, United States
- Saint Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Disney Family Cancer Center
Burbank, California, United States
- Scripps Clinical Research Services
La Jolla, California, United States
- Ucla Medical Center
Los Angeles, California, United States
- Palo Alto Medical Foundation
Mountain View, California, United States
- Los Palos Oncology and Hematology
Salinas, California, United States
- Sharp Memorial Hospital
San Diego, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- Rocky Mountain Cancer Centers
Denver, Colorado, United States
- Hematology Oncology Associates, Pc
Stamford, Connecticut, United States
- Florida Cancer Institute - New Hope
New Port Richey, Florida, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Martin Memorial Cancer Center
Stuart, Florida, United States
- Atlanta Cancer Care
Atlanta, Georgia, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer
Indianapolis, Indiana, United States
- Purchase Cancer Group
Paducah, Kentucky, United States
- Medical Oncology
Baton Rouge, Louisiana, United States
- Ochsner Cancer Institute
New Orleans, Louisiana, United States
- Lsu Health Sciences Center - Feist Weiller Cancer Center
Shreveport, Louisiana, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Massachusetts Medical Center
Worcester, Massachusetts, United States
- Virgina Piper Cancer Institute
Minneapolis, Minnesota, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Hematology and Oncology Associates at Bridgepoint
Tupelo, Mississippi, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- Montana Cancer Institute Foundation
Missoula, Montana, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- New York Oncology Hematology, P.C.
Hudson, New York, United States
- Cancer Care of Western North Carolina, Pa
Asheville, North Carolina, United States
- Alamance Oncology Hematolgy Associates
Burlington, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Carolina Oncology Specialists, Pa
Hickory, North Carolina, United States
- Emerywood Hematology and Oncology
High Point, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 30 Sept 2013
- Completion
- 31 Dec 2014
- Last update posted
- 11 May 2025
- Registered enrollment
- 214
- Registry id
- NCT01144455
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.